HIV drugs tested on psoriasis in groundbreaking skin study

NCT ID NCT04274595

Summary

This small, completed study tested whether medications used to treat HIV (reverse transcriptase inhibitors) could help control psoriasis. Researchers gave these drugs to 8 people with long-term plaque psoriasis to see if they could reduce skin inflammation and improve lesions. The main goal was to check if the treatment blocked a specific cellular marker in skin biopsies, not primarily to measure symptom relief.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU de Montpellier

    Montpellier, 34295, France

  • CHU de Nimes

    Nîmes, 30029, France

Conditions

Explore the condition pages connected to this study.